Company Filing History:
1 out of 44 
1 out of 4 Years Active: 2015
Title: Innovations of Chandrashekar Reddy Kottam
Introduction
Chandrashekar Reddy Kottam is an accomplished inventor based in Shadnagar, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial agents. His innovative work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Chandrashekar Reddy Kottam holds a patent for "Substituted pyridine derivatives as FabI inhibitors." This invention provides substituted pyridine derivatives of formula (I), which may be therapeutically useful as antibacterial agents, specifically as FabI inhibitors. The patent outlines the formula in which R1 to R5 and L have specific meanings, along with pharmaceutically acceptable salts that are beneficial in treating and preventing diseases or disorders. The invention also details methods for synthesizing and administering the FabI inhibitor compounds, as well as pharmaceutical formulations that include these compounds along with suitable carriers, diluents, or excipients.
Career Highlights
Throughout his career, Chandrashekar has worked with notable companies such as Aurigene Discovery Technologies Limited and Um Pharmauji Sdn. Bhd. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Chandrashekar has collaborated with professionals like Mohamed Takhi and Subramanya Hosahalli, enhancing his research and development efforts in the pharmaceutical industry.
Conclusion
Chandrashekar Reddy Kottam's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the development of effective antibacterial agents, showcasing the importance of innovation in healthcare.